Seller record · simplepeptide.com

Simple Peptide

Recorded September 2026 · Standard v1.1

Fails 3 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed on any of the eleven pages read, and the terms set a minimum age of twenty one and a self-asserted qualified researcher status. 2 more criteria also fail; see the table below.

Research vendor. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A research peptide seller trading from a Florida address, offering vials, capsules, blends and skincare compounds. Its catalog index, cart and checkout each sit behind an account wall, while individual product pages and the certificate library stay readable without one.

Operating entity Footer, contact, terms and privacy were read, and no legal entity name appears on any of them.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	simplepeptide.com/terms-conditions
S2	Prescription gating	FAIL	simplepeptide.com/checkout
S3	Pharmacy identification	FAIL	simplepeptide.com/terms-conditions
S4	Compounding disclosure	PASS	simplepeptide.com/terms-conditions
S5	Analytical documentation	PASS	simplepeptide.com/wp-content/uploads/2024/07/sema-10.webp
S6	Business address	PASS	simplepeptide.com/contact
S7	Price disclosure	PASS	simplepeptide.com/product/bpc-157
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician evaluation is claimed on any of the eleven pages read, and the terms set a minimum age of twenty one and a self-asserted qualified researcher status.Source: simplepeptide.com/terms-conditions.

S2FAILThe order path was walked from the BPC-157 page, the item added to the cart, and the cart and the checkout then each redirected to an account wall.Source: simplepeptide.com/checkout.

S3FAILNo pharmacy is named on any of the eleven pages read, and the terms state that the seller is not a compounding pharmacy under section 503A.Source: simplepeptide.com/terms-conditions.

S4PASSThe seller offers no compounded drug, and a footer notice on every page read states that the products are not approved by the Food and Drug Administration.Source: simplepeptide.com/terms-conditions.

S5PASSA public certificate from Freedom Diagnostics gives 99.92 percent purity on semaglutide lot P24102404 by HPLC with mass spectrometry, reachable with no login.Source: simplepeptide.com/wp-content/uploads/2024/07/sema-10.webp.

S6PASSA footer on all eleven pages read prints a street address with a suite number at 6586 West Atlantic Avenue in Delray Beach, Florida.Source: simplepeptide.com/contact.

S7PASSThe BPC-157 page prints a range from 55.00 dollars through 85.00 dollars with an add to cart control and no account, while the catalog index that lists prices together requires one.Source: simplepeptide.com/product/bpc-157.

S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including semaglutide, BPC-157 and semax, peptide capsules and blends, skincare compounds, exosome preparations, laboratory devices.

Sellers passing S1, prescriber requirement

Records dated August 2026

Records dated September 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.